ILMN

103.03

2.14% 2.16

Dopo l'orario di chiusura: 102.22 -0.81 -0.79%

Illumina Inc (ILMN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ILMN Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$100.87

Aprire:

$102.31

Volume 24 ore:

1.14M

Relative Volume:

0.59

Capitalizzazione di mercato:

$15.84B

Reddito:

$4.28B

Utile/perdita netta:

$1.26B

Rapporto P/E:

13.04

EPS:

7.9

Flusso di cassa netto:

$943.00M

1 W Prestazione:

+3.75%

1M Prestazione:

+2.49%

6M Prestazione:

+20.98%

1 anno Prestazione:

-21.33%

Intervallo 1D:

$101.60

$103.78

Intervallo di 1 settimana:

$95.12

$104.22

Portata 52W:

$68.70

$156.66

Illumina Inc Stock (ILMN) Company Profile

Nome

Illumina Inc

Settore

Healthcare (1149)

Industria

Diagnostics & Research (53)

Telefono

(858) 202-4500

Indirizzo

5200 ILLUMINA WAY, SAN DIEGO, CA

Dipendente

8,970

Cinguettio

@illumina

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

ILMN's Discussions on Twitter

Confronta ILMN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ILMN Illumina Inc	103.03	15.50B	4.28B	1.26B	943.00M	7.90
TMO Thermo Fisher Scientific Inc	481.10	178.47B	43.21B	6.58B	6.17B	17.29
DHR Danaher Corp	195.27	138.15B	24.01B	3.41B	4.86B	4.70
IDXX Idexx Laboratories Inc	655.51	51.27B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	127.62	35.93B	6.79B	1.22B	1.09B	4.26
IQV Iqvia Holdings Inc	190.20	31.74B	15.70B	1.24B	2.01B	6.91

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-12	Downgrade	Daiwa Securities	Outperform → Neutral
2025-07-11	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	Reiterato	Citigroup	Neutral
2025-02-28	Downgrade	HSBC Securities	Buy → Hold
2025-02-10	Downgrade	Barclays	Equal Weight → Underweight
2025-02-07	Downgrade	TD Cowen	Buy → Hold
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-11-12	Ripresa	Morgan Stanley	Equal-Weight
2024-10-17	Aggiornamento	HSBC Securities	Hold → Buy
2024-08-28	Aggiornamento	Argus	Hold → Buy
2024-08-16	Aggiornamento	Daiwa Securities	Neutral → Buy
2024-08-14	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-14	Aggiornamento	TD Cowen	Hold → Buy
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-03	Ripresa	Jefferies	Hold
2024-01-16	Downgrade	HSBC Securities	Buy → Hold
2024-01-04	Downgrade	TD Cowen	Outperform → Market Perform
2023-12-18	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	Aggiornamento	Bernstein	Underperform → Mkt Perform
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-14	Iniziato	Stephens	Overweight
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Neutral → Underperform
2023-12-11	Aggiornamento	Citigroup	Sell → Neutral
2023-11-10	Downgrade	Canaccord Genuity	Buy → Hold
2023-09-28	Iniziato	Bernstein	Underperform
2023-07-05	Ripresa	JP Morgan	Neutral
2023-01-25	Downgrade	Argus	Buy → Hold
2023-01-05	Iniziato	Scotiabank	Sector Perform
2022-12-12	Downgrade	Citigroup	Neutral → Sell
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-04	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-09-28	Aggiornamento	Evercore ISI	In-line → Outperform
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-07-13	Downgrade	Barclays	Equal Weight → Underweight
2022-01-18	Aggiornamento	Stifel	Hold → Buy
2022-01-11	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-07	Aggiornamento	BofA Securities	Underperform → Neutral
2022-01-06	Ripresa	Morgan Stanley	Equal-Weight
2022-01-06	Ripresa	Piper Sandler	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-03-31	Downgrade	Atlantic Equities	Overweight → Neutral
2021-03-31	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-03-03	Iniziato	Barclays	Underweight
2020-12-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-17	Aggiornamento	BTIG Research	Neutral → Buy
2020-10-13	Downgrade	Guggenheim	Buy → Neutral
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-09-22	Downgrade	Stifel	Buy → Hold
2020-09-22	Downgrade	UBS	Buy → Neutral
2020-09-21	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-21	Downgrade	JP Morgan	Overweight → Neutral
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-08-07	Downgrade	Evercore ISI	In-line → Underperform
2020-08-07	Downgrade	Piper Sandler	Overweight → Neutral
2020-07-07	Downgrade	Guggenheim	Buy → Neutral
2020-04-24	Downgrade	Citigroup	Buy → Neutral
2020-04-21	Downgrade	Robert W. Baird	Outperform → Neutral
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Iniziato	Citigroup	Buy
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-11-15	Iniziato	Stifel	Buy
2019-10-25	Iniziato	Guggenheim	Buy

Mostra tutto

Illumina Inc Borsa (ILMN) Ultime notizie

12:37 PM

Video: Illumina staff share who inspired them to work in genomics - Illumina

12:37 PM

09:16 AM

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine - Illumina

09:16 AM

09:15 AM

250,000 Genome Database Gets Major Boost: Alnylam Joins Elite Pharma Alliance for Breakthrough Drug Discovery - Stock Titan

09:15 AM

07:27 AM

US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux - Yahoo Finance

07:27 AM

04:37 AM

Bioinformatics Market Evolution by 2032Disruptive Innovations, Regional Insights, and Growth Opportunities | Active Motif, Inc., Illumina, Inc. - industrytoday.co.uk

04:37 AM

03:20 AM

Illumina, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo

03:20 AM

Sep 17, 2025

Gainers Report: What’s next for Illumina Inc. stock2025 Trade Ideas & Low Risk High Win Rate Picks - خودرو بانک

Sep 17, 2025

Returns Recap: Will Illumina Inc. announce a stock split2025 Price Action Summary & Capital Protection Trade Alerts - خودرو بانک

Sep 16, 2025

Epigenetics Market Outlook (2025–2032) : Strategic Growth Insights, Revenue Trends and Innovation Amidst Leaders Like Illumina Inc., Thermo Fisher Scientific Inc. - industrytoday.co.uk

Sep 16, 2025

Aug Gainers: Can Illumina Inc stock outperform in a bear marketQuarterly Performance Summary & Reliable Entry Point Trade Alerts - خودرو بانک

Sep 16, 2025

Loss Report: Can Illumina Inc stock outperform in a bear market2025 Market WrapUp & Long Hold Capital Preservation Plans - خودرو بانک

Sep 16, 2025

Sep 15, 2025

How an Illumina bioinformatics engineer contributes to the company mission - Illumina

Sep 15, 2025

Buy Signal: Is Illumina Inc. a strong growth stockMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - خودرو بانک

Sep 15, 2025

EV Market: How does Illumina Inc. score in quality rankings2025 Key Highlights & Growth Focused Entry Reports - خودرو بانک

Sep 15, 2025

Sep 14, 2025

Precision Genomic Testing Market May See a Big Move | Major Giants- Illumina, BGI Genomics, Agilent Technologies - openPR.com

Sep 14, 2025

Alliancebernstein L.P. Sells 1,385,581 Shares of Illumina, Inc. $ILMN - MarketBeat

Sep 14, 2025

Plato Investment Management Ltd Sells 2,855 Shares of Illumina, Inc. $ILMN - MarketBeat

Sep 14, 2025